Mehmet Kadri Akboga

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 11

Top Topics

Acute Coronary Syndrome

St Elevation Myocardial Infarction

Antiplatelet Therapy

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Mehmet Kadri Akboga, Ibrahim Halil Inanc, Cengiz Sabanoglu, Ahmet Akdi, Idris Yakut, Baran Yuksekkaya, Serdar Gökhan Nurkoç, Mehmet R Yalçın
Predictors of Acute Stent Thrombosis and High SYNTAX Score in Acute Coronary Syndrome. Angiology (2023)
Mehmet Kadri Akboga, Ibrahim Halil Inanc, Cengiz Sabanoglu, Ahmet Akdi, İdris Yakut, Baran Yuksekkaya, Serdar Gökhan Nurkoç, Mehmet R Yalçın
Systemic Immune-Inflammation Index and C-Reactive Protein/Albumin Ratio Could Predict Acute Stent Thrombosis and High SYNTAX Score in Acute Coronary Syndrome. Angiology (2022)
Mehmet Kadri Akboga, Ibrahim Halil Inanc
Plasma Leukocyte Cell-Derived Chemotaxin 2 for the Severity of Coronary Artery Disease. Angiology (2021)
Mehmet Kadri Akboga, Mehmet R Yalçın
Letter Circulating microRNA-221 and 222 for the Severity of Coronary Artery Disease in Acute Coronary Syndrome. Angiology (2021)
Mehmet Kadri Akboga, Ibrahim Halil Inanc, Ridvan Yalcin
Promising Parameters in Predicting High SYNTAX II Score and In-Hospital Mortality for Non-ST-Elevation Myocardial Infarction. Angiology (2021)
Mehmet Kadri Akboga, Yesim Eylev Akboga, Sercan Okutucu, Ridvan Yalcin
Is It Possible to Predict Contrast-Induced Nephropathy With Single Parameter or Ratio? Better to Include Easily Available Indices. Angiology 70 (10) (2019)
Mehmet Kadri Akboga, Yesim Eylev Akboga
Endocan at the Crossroads: A Vasculoprotective Molecule or Inflammatory Marker? Angiology 70 (7) (2019)
Cengiz Sabanoglu, Mehmet Kadri Akboga, Sercan Okutucu
Inflammatory Biomarkers for Predicting High SYNTAX and SYNTAX II Scores. Angiology 70 (4) (2018)
Mehmet Kadri Akboga, Sercan Okutucu, Cengiz Sabanoglu, Cagri Yayla, Ahmet Goktug Ertem, Tolga Han Efe
Are Endocan and Ischemia-Modified Albumin Reliable Biomarkers for Endothelial Dysfunction in Type 2 Diabetes Mellitus? Angiology 71 (5) (2018)
Mehmet Kadri Akboga, Samet Yilmaz
Predictors of In-Stent Restenosis. Angiology 70 (3) (2018)
Mehmet Kadri Akboga, Koray Demirtas, Cagri Yayla, Sefa Unal
Is Endocan an Inflammatory Marker or an Angiogenic Marker, or Both or None? Angiology 69 (1) (2017)